List view / Grid view
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
12 May 2017 | By Niamh Marriott, Junior Editor
St. Jude Children’s Research Hospital and the Serum Institute of India will develop & commercialise a vaccine against the respiratory syncytial virus (RSV).
3 June 2016 | By Victoria White, Digital Content Producer
Neuroblastoma tumours shrank in 80% of young, high-risk patients enrolled in a Phase II clinical trial that included an experimental monoclonal antibody...
